CLVT.NYSEClarivate PLC

DEF 14A: Clarivate Sets Date for 2024 Annual General Meeting, Outlines Key Proposals

Sentiment:

Proxy Statement


Clarivate Plc will hold its 2024 Annual General Meeting of Shareholders on May 7, 2024, to vote on director elections, executive compensation, and the ratification of its independent auditor.

Summary

  • Clarivate Plc will hold its Annual General Meeting on May 7, 2024, at its corporate headquarters in London.
  • Shareholders of record as of March 8, 2024, are eligible to vote.
  • The meeting will address the election of 12 director nominees, an advisory vote on executive compensation, and the ratification of PricewaterhouseCoopers LLP as the company's independent registered public accountants for fiscal year 2024.
  • The Board of Directors recommends voting FOR each director nominee and FOR Proposals 2 and 3.
  • Proxy materials are available online and can be requested by mail or phone.
  • Shareholders can vote via internet, QR code, email, or mail, with specific deadlines for each method.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, presenting information in a neutral and informative tone. The recommendations are positive, but the overall sentiment is balanced.

Positives

  • The Board of Directors is actively soliciting shareholder input and participation in key decisions.
  • The company provides multiple avenues for shareholders to cast their votes, including online, email, and mail.
  • The company has retained D.F. King & Co., Inc. to aid in the solicitation of proxies.

Risks

  • The document contains forward-looking statements that are subject to risks and uncertainties, as detailed in the company's Annual Report.
  • Failure to provide voting instructions to brokers may result in unvoted shares on certain proposals.

Future Outlook

The proxy statement includes forward-looking statements regarding future events and results, which are subject to risks and uncertainties.

Management Comments

  • Jonathan Gear, Chief Executive Officer, thanks shareholders for their continued support of Clarivate.
  • The Board of Directors recommends that you vote FOR each Director nominee included in Proposal 1 and FOR Proposals 2 and 3 as listed in the attached notice.

Industry Context

The document does not explicitly discuss industry context, but the proposals relate to standard corporate governance practices for publicly traded companies.

Related Party Transactions

  • Clarivate assumed a Finance lease in which CIG is the lessor. Mr. Snyder serves as Chief Executive Officer of CIG.
  • Mr. Snyder is affiliated with a Clarivate vendor and customer. During the year ended December 31, 2023, the Company recognized revenues, net of $1,400 and incurred expenses of $4,900 related to such vendor and customer arrangement.

Stakeholder Impact

  • Shareholders are directly impacted by the proposals being voted on, including the election of directors and executive compensation.
  • Employees are indirectly impacted through the approval of executive compensation and the overall governance of the company.

Next Steps

  • Shareholders are encouraged to review the proxy materials and submit their votes before the specified deadlines.
  • Attend the Annual General Meeting on May 7, 2024, or listen via webcast.

Key Dates

DateDescription
March 8, 2024Record date for determining shareholders eligible to vote.
March 25, 2024Proxy Statement and Annual Report first distributed or made available.
April 19, 2024Deadline to mail proxy card to ensure receipt by May 3, 2024.
May 3, 2024Deadline for internet and email voting (11:59 p.m. Eastern Time).
May 7, 2024Annual General Meeting date.
November 25, 2024Deadline for shareholder proposals to be included in the 2025 Proxy Statement.

Keywords

Annual General Meeting, Proxy Statement, Shareholders, Directors, Executive Compensation, PricewaterhouseCoopers, Voting, Clarivate

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.